Selective inhibitor of ribosomal S6 kinase (RSK) (IC50
= 89 nM for RSK2). Does not inhibit upstream kinases such as MEK, Raf and PKC.� Inhibits the growth of MCF-7 human breast cancer cells with no effect on the normal breast cell line.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Identification of the first specific inhibitor of p90 ribosomal S6 kinase (RSK) reveals an unexpected role for RSK in cancer cell proliferation.
Smith et al.
Cancer Res., 2005;65:1027
The selectivity of protein kinase inhibitors: a further update.
Bain et al.
ERK1/2 regulates ANG II-dependent cell proliferation via cytoplasmic activation of RSK2 and nuclear activation of elk1.
Godeny and Sayeski
The citations listed below are publications that use Tocris products. Selected citations for SL 0101-1 include:
Showing Results 1 - 6 of 6